544 related articles for article (PubMed ID: 30773660)
1. Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis.
Armstrong MJ; Gohar F; Dhaliwal A; Nightingale P; Baker G; Greaves D; Mangat K; Zia Z; Karkhanis S; Olliff S; Mehrzad H; Steeds RP; Tripathi D
Aliment Pharmacol Ther; 2019 Mar; 49(6):797-806. PubMed ID: 30773660
[TBL] [Abstract][Full Text] [Related]
2. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
Jalan R; Elton RA; Redhead DN; Finlayson ND; Hayes PC
J Hepatol; 1995 Aug; 23(2):123-8. PubMed ID: 7499782
[TBL] [Abstract][Full Text] [Related]
3. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
[TBL] [Abstract][Full Text] [Related]
4. Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.
Zhu P; Dong S; Sun P; Belgaumkar AP; Sun Y; Cheng X; Zheng Q; Li T
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012358. PubMed ID: 37531575
[TBL] [Abstract][Full Text] [Related]
5. A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt.
Jalan R; Gooday R; O'Carroll RE; Redhead DN; Elton RA; Hayes PC
J Hepatol; 1995 Dec; 23(6):697-705. PubMed ID: 8750169
[TBL] [Abstract][Full Text] [Related]
6. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt.
Rabie RN; Cazzaniga M; Salerno F; Wong F
Am J Gastroenterol; 2009 Oct; 104(10):2458-66. PubMed ID: 19532126
[TBL] [Abstract][Full Text] [Related]
7. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt.
Cazzaniga M; Salerno F; Pagnozzi G; Dionigi E; Visentin S; Cirello I; Meregaglia D; Nicolini A
Gut; 2007 Jun; 56(6):869-75. PubMed ID: 17135305
[TBL] [Abstract][Full Text] [Related]
8. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
[TBL] [Abstract][Full Text] [Related]
9. Study protocol for a Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in Acute Variceal Bleeding (REACT-AVB trial).
Tripathi D; Patch D; Mehrzad H; Yu D; Aspinall RJ; Armstrong MJ; Stanley A; Ireland H; Travis S; Hayes P; Lomax M; Roslund N; Lam E; Slinn G; Jowett S; Moakes C; Maher A; Brettell E; Sehmi S;
BMJ Open Gastroenterol; 2024 Mar; 11(1):. PubMed ID: 38519049
[TBL] [Abstract][Full Text] [Related]
10. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding.
Rössle M; Haag K; Ochs A; Sellinger M; Nöldge G; Perarnau JM; Berger E; Blum U; Gabelmann A; Hauenstein K
N Engl J Med; 1994 Jan; 330(3):165-71. PubMed ID: 8264738
[TBL] [Abstract][Full Text] [Related]
11. Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.
Praktiknjo M; Abu-Omar J; Chang J; Thomas D; Jansen C; Kupczyk P; Schepis F; Garcia-Pagan JC; Merli M; Meyer C; Strassburg CP; Pieper CC; Trebicka J
JHEP Rep; 2021 Jun; 3(3):100264. PubMed ID: 34013182
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.
Tan HK; James PD; Sniderman KW; Wong F
J Gastroenterol Hepatol; 2015 Feb; 30(2):389-95. PubMed ID: 25168607
[TBL] [Abstract][Full Text] [Related]
13. Misplacement of transjugular intrahepatic portosystemic shunts: A surgical challenge for liver transplantation?
Addeo P; Schaaf C; Faitot F; Terrone A; Julliard O; Besch C; Serfaty L; Bachellier P
Surgery; 2021 Feb; 169(2):447-454. PubMed ID: 32868109
[TBL] [Abstract][Full Text] [Related]
14. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
15. Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis.
Schneider H; Berliner D; Stockhoff L; Reincke M; Mauz JB; Meyer B; Bauersachs J; Wedemeyer H; Wacker F; Bettinger D; Hinrichs JB; Maasoumy B
United European Gastroenterol J; 2023 Nov; 11(9):837-851. PubMed ID: 37897707
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
Teng D; Zuo H; Liu L; Dong J; Ding L
Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
[TBL] [Abstract][Full Text] [Related]
17. Prediction of mortality and overt hepatic encephalopathy undergoing transjugular intrahepatic portosystemic shunt: a retrospective cohort study.
Li K; Cheng Y; Zhao R; Jiang H; Zhang L; Tong Y; Li S
Abdom Radiol (NY); 2024 Mar; 49(3):908-918. PubMed ID: 37957372
[TBL] [Abstract][Full Text] [Related]
18. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
[TBL] [Abstract][Full Text] [Related]
19. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
[TBL] [Abstract][Full Text] [Related]
20. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt.
Huonker M; Schumacher YO; Ochs A; Sorichter S; Keul J; Rössle M
Gut; 1999 May; 44(5):743-8. PubMed ID: 10205217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
